Accreditation strategy for rare somatic molecular abnormalities detected or quantified by polymerase chain reaction: GBMHM recommendations.
Sign Up to like & getrecommendations! Published in 2019 at "Annales de biologie clinique"
DOI: 10.1684/abc.2019.1498
Abstract: In 2020, accreditation of molecular tests according to ISO 15189 is a requirement for all French medical laboratories. For many years, the GBMHM group (French Group of Molecular Biologists in Hematology) supports this approach through… read more here.
Keywords: accreditation strategy; accreditation; rare somatic; strategy rare ... See more keywords